Ireland’s New Public Health Strategy Is the Commercial Case for Private Sector Investment in Prevention

Healthcare systems that invest in prevention consistently outperform those that manage disease reactively. The HSE Public Health Strategy 2025–2030, launched 11 December 2025, sets out an ambitious five-year vision anchored in population health, early intervention, and health equity across six priority areas. It is the most significant preventive health statement from the Irish public system in a decade, and the commercial case for private sector participation has never been stronger.

The strategy frames prevention as a whole-society endeavour. Private providers — hospitals, insurers, and corporate wellness operators — are positioned to deliver the screening and early intervention the strategy demands but that public capacity alone cannot supply. The OECD State of Health in the EU: Ireland 2025, published December 2025, confirms cancer accounted for over a quarter of Irish deaths in 2022 and that asthma and COPD admissions run more than double the EU average. Prevention is a genuine clinical necessity.

The chronic disease burden defines the scale of the opportunity. The HSE Integrated Care Programme for Chronic Disease confirms that approximately one million people in Ireland live with diabetes, asthma, COPD, or cardiovascular disease, with 64.8% of those over 65 managing two or more conditions simultaneously. Private providers with rapid-access diagnostics and nurse-led chronic disease clinics can absorb a meaningful share of this cohort, with the NTPF outsourcing framework providing a proven funding pathway.

The insurance sector is already moving in the same direction. The Insurance Ireland and Milliman report, published December 2025, identifies private insurers as catalysts for preventive innovation, noting growing adoption of ambulatory clinics and digital consultations. With over €3 billion in claims paid in 2024, insurers have a clear financial incentive to shift members toward earlier intervention. Health screening is embedded in higher-tier plans; the opportunity is to extend it across the full 2.55 million-strong insured population.

Corporate Ireland is the most immediately scalable channel. Employer-sponsored screening addresses the working-age population — the cohort least likely to present to primary care until symptoms are advanced. The HSE strategy’s emphasis on health equity creates a direct policy alignment with workplace wellness that private providers can cite in partnership conversations. Employer investment in preventive health reduces absenteeism, lowers group insurance claims, and improves talent retention — a proposition that resonates with the C-suite.

Three actions will convert policy alignment into revenue. First, develop structured surveillance programmes covering cardiovascular, respiratory, and metabolic risk for clinical and workplace settings, with outcomes data suitable for HSE and insurer commissioning. Second, work with the HIA and insurers to standardise health screening as a core plan benefit, broadening access and volume. Third, build referral pathways from screening into private specialist services, creating an integrated prevention-to-treatment model that delivers value to employers, insurers, and the public system.

Ireland’s public health ambition is clearly articulated; the question is who delivers it. Providers that position themselves as partners in prevention will access a growing patient population, strengthen insurer relationships, and demonstrate the system-level value that secures long-term public partnership. Prevention is the next strategic frontier for Irish private healthcare.

(The views expressed by the writer are his/her own and do not necessarily reflect the views or positions of BusinessRiver.)